Mutant FLT3 modulates nuclear transcription programs to upregulate SUCLG1 expression and mitochondrial genes, resulting in mitobiogenesis remodeling and AML progression (Fig. 6Q). Here, FLT3 is linked to acute myeloid leukemia.